Trial intelligence / Profile preview

Effect of Simvastatin Withdrawal on Ocular Endothelial Function

NCT02533141Phase 4Withdrawn

Sponsor
Medical University of Vienna
Start
Oct 2019
Primary completion
Sep 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of simvastatin in hypercholesterolemia, sponsored by Medical University of Vienna. Planned start Oct 2019; status: withdrawn.

02

Drugs

simvastatin
03

Conditions

hypercholesterolemia

Beyond the preview

Go deeper on NCT02533141.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02533141.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call